On Fri, Sep 13, 2019 at 1:43 PM Heather Morrison < [email protected]> wrote:
> Thank you Peter. > > I respectfully disagree. If Elsevier is retaining copyright and using an > NC license, they have a right to sell the work and CCC has a right to > coordinate. Elsevier practice is copyright in the name of the author with > exclusive rights granted to Elsevier. > > Elsevier are not the copyright holders: >>>>> Copyright © 2019 The Author(s). Published by Elsevier Inc. User LicenseCreative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0) <http://creativecommons.org/licenses/by-nc-nd/4.0/> | How you can reuse <https://www.cell.com/cell/fulltext/S0092-8674(19)30626-9#> [image: Information Icon] >>>>>> However Elsevier are strongly asserting on CCC/Rightslink that they control the re-use of this >>Permission Not Allowed >>According to the policies of Elsevier, use of this content in the manner you are requesting is not allowed. It is about time that the Universities and Libraries and Funders challenge this. It's nothing to do with "arXiv". The authors have, in good faith, paid Elsevier huge amounts of money to buy "open access" and Elsevier have published it in a framework where they assert all reuse-rights Yes, there's a chance that if Elsevier took the re-users to court they re-users might be vindicated, but that's not open access. This is close to copyfraud. -- "I always retain copyright in my papers, and nothing in any contract I sign with any publisher will override that fact. You should do the same". Peter Murray-Rust Reader Emeritus in Molecular Informatics Unilever Centre, Dept. Of Chemistry University of Cambridge CB2 1EW, UK +44-1223-763069
_______________________________________________ GOAL mailing list [email protected] http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
